Patient Platform Reach Carenity operates a large online patient community with over 500,000 active members across Europe and North America, presenting a ready-made access point for real-world evidence studies, patient recruitment, and longitudinal patient insights for life sciences clients.

Medical Research Focus As a digital CRO services provider with proven collaboration on more than 500 scientific publications, Carenity offers experienced patient-centric research capabilities, enabling sponsors to design and execute online prospective direct-to-patient studies and access robust real-world data.

Global disease Access Access spans thousands of patients across 1,200+ diseases, allowing rapid targeting and recruitment for diverse therapeutic areas, which can accelerate trial recruitment timelines and improve study representativeness for sponsors.

Part of EvidentIQ Since 2021 Carenity operates under the EvidentIQ Group, signaling additional resources and potential cross-sell opportunities with EvidentIQ’s ecosystem, expanding service offerings and data capabilities to existing clients.

Low Revenue, High Potential Current revenue is under 1M, indicating a small but scalable footprint with high upside for scale through expanded partnerships, industry collaborations, and expanded service lines such as direct-to-patient studies and data analytics.